[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-341090-105":59,"doc-detail-341090-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","ideas-an-interactive-database-for-dysregulated-alternative-splicing-in-cancers-across-chinese-and-western-patients","IDeAS - an interactive database for dysregulated alternative splicing in cancers across Chinese and western patients","","Splicing of pre-RNA is fundamental to eukaryotic gene regulation, and dysregulated alternative splicing drives cancer development and progression. Many existing resources rely mainly on European–American cohorts, leaving gaps due to genetic and lifestyle differences and incomplete coverage of splicing regulators. IDeAS is an interactive database integrating TCGA and multiple Chinese tumor RNA-seq datasets, including 215,000+ ASEs, unified reanalysis, and a user-friendly interface for browsing, visualizing, downloading, and exploring clinical impacts such as survival analyses.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/ideas-an-interactive-database-for-dysregulated-alternative-splicing-in-cancers-across-chinese-and-western-patients/341090/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/ideas-an-interactive-database-for-dysregulated-alternative-splicing-in-cancers-across-chinese-and-western-patients/341090.png","ImageObject",300,407,{"name":92,"@type":93},"Ava Thompson","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What problem does IDeAS address in cancer alternative splicing research?","Question",{"text":112,"@type":113},"IDeAS addresses the limited representation of non-European–American patient populations and the insufficient discussion of splicing factors affecting cancer-associated splicing in previous databases.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which datasets were integrated to build IDeAS?",{"text":117,"@type":113},"IDeAS integrates TCGA project data with multiple Chinese tumor RNA-seq datasets collected as Chinese Tumor Transcriptomics Archive (CTTA).",{"name":119,"@type":110,"acceptedAnswer":120},"How were alternative splicing events processed and integrated in IDeAS?",{"text":121,"@type":113},"Raw RNA-seq data were reanalyzed using a unified pipeline with two tools, Paean and rMATS, and 215,773 ASEs were qualified and integrated, including many novel events.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},341090,1790641061,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":19,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":52,"preview_page_count":19,"preview_urls":144},1649267921044,"https://us-avatar.wpscdn.com/avatar/1800007509477c92dfb?_k=1786009248482753345","Journal of Molecular Cell Biology (2023), 15(11), mjad074 [https://doi.org/10.1093/jmcb/mjad074](https://doi.org/10.1093/jmcb/mjad074)  \nPublished online November 27, 2023  \nApplication Note  \nIDeAS: an interactive database for dysregulated alternative splicing in cancers across Chinese and western patients  \nSplicing of pre-RNA is a key step in regulating eukaryotic gene expression. Most human genes undergo alternative splicing (AS), where the splice sites in a single gene can be selectively paired to produce multiple isoforms, greatly expanding the functional diversity (Pan et al., 2008 ; Wang et al., 2008) . The regulation of AS plays a critical role in many cellular activities, such as cell diﬀerentiation. Therefore, the dysregulation of AS can lead to a variety of diseases, including cancers (Scotti and Swanson, 2016) . Multiple lines of evidence have shown that mutations in several splicing regulatory cis-elements and/or the dysregulation of splicing factors can lead to splicing alterations, which are closely related to biological processes of tumorigenesis and progression, including invasion, apoptosis, proliferation, etc. (Bonnal et al., 2020 ; Wang et al., 2020) .  \nStudying dysregulated AS events (ASEs) in cancers is important for understanding tumorigenesis and ﬁnding new therapeutic targets. Recently, several studies have analyzed large-scale tumor RNA-seq data to systematically identify cancer-associated splicing events, explore potential upstream regulators, and predict their eﬀectson downstream pathways. These data were deposited in diﬀerent databases, including Oncosplicing (Zhang et al., 2021), lncAS2Cancer (Deng et al., 2021), CancerSplicingQTL (Tian et al., 2019),  \nThis is an Open Access article distributed under the terms of the Creative Commons AttributionNonCommercial License ([https://creativecommons](https://creativecommons). org/licenses/by-nc/4.0/), which permits noncommercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact [journals.permissions@oup.com](journals.permissions@oup.com)  \nand ExonSkipDB (Kim et al., 2020), which can be downloaded by researchers. However, nearly all these analyses were based on European–American cancer cohorts in The Cancer Genome  \nAtlas (TCGA) or Gene Expression Omnibus (GEO) datasets, which maybe biased by the unique genetic background and lifestyle of this patient population. Considering the high cancer heterogeneity and the diﬀerence in splicing regulation across distinct patient populations (Lu et al., 2012), a comprehensive analysis of AS in other patient populations is necessary. In addition, the analysis of splicing regulators in the previous databases was insuﬃcient. For example, the splicing quantitative trait loci (QTLs) aﬀecting AS in cancers were identiﬁed in CancerSplicingQTL; however, this database did not discuss the splicing factors involved in the regulation of cancer-associated splicing. Therefore, an integrative analysis combining the whole-transcriptome binding and functional maps of multiple splicing factors will deepen the understanding of how AS is misregulated in cancers.  \nTo this end, we developed an interactive database for dysregulated alternative splicing (IDeAS) in cancers, which contains splicing patterns of > 215000 ASEs by integrating the TCGA project and multiple Chinese tumor RNA-seq datasets (Supplementary Data summary and Figure S1) . In total, IDeAS contains data from 9913 tumor samples and 730 adjacent normal samples across 33 tumor types in the TCGA project (Heath et al., 2021), as well as 923 tumor samples and 556 normal samples collected from 11 Chinese tumor  \nstudies (Figure 1) . Nine tumor types were present in both patient populations: bladder cancer, breast cancer, colorectal cancer, glioma, head and neck cancer, liver cancer, lung cancer, prostate cancer, and renal cell cancer. Two datasets were collected for Chinese breast cancer an","cbCaiatvNKcrYBYT","https://ap.wps.com/l/cbCaiatvNKcrYBYT","pdf",411636,"English","# Splicing dysregulation and the need for integrated resources\n# Limitations of existing cancer splicing databases\n# IDeAS database design and data collection\n## Coverage across tumor types and Chinese cohorts\n## Unified pipeline and ASE integration\n# Access, interface, and functional modules","[{\"question\":\"What problem does IDeAS address in cancer alternative splicing research?\",\"answer\":\"IDeAS addresses the limited representation of non-European–American patient populations and the insufficient discussion of splicing factors affecting cancer-associated splicing in previous databases.\"},{\"question\":\"Which datasets were integrated to build IDeAS?\",\"answer\":\"IDeAS integrates TCGA project data with multiple Chinese tumor RNA-seq datasets collected as Chinese Tumor Transcriptomics Archive (CTTA).\"},{\"question\":\"How were alternative splicing events processed and integrated in IDeAS?\",\"answer\":\"Raw RNA-seq data were reanalyzed using a unified pipeline with two tools, Paean and rMATS, and 215,773 ASEs were qualified and integrated, including many novel events.\"}]","IDeAS - an interactive database for dysregulated alternative splicing in cancers across Chinese and western patients | PDF",1790040273,[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1450898f3fee2b7655a20b07ad4fc723.webp",983,1269,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/658a16fa3c3555ea6be3a860c6854919.webp",982,1268,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/968ac101b52d099e5c67f54836772a6d.webp",981,1266,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4432caab29abbfe488cff8bb71c4b7e0.webp",980,1265]